Jing Lü

8.7k total citations · 2 hit papers
189 papers, 6.8k citations indexed

About

Jing Lü is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jing Lü has authored 189 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Molecular Biology, 31 papers in Cardiology and Cardiovascular Medicine and 28 papers in Oncology. Recurrent topics in Jing Lü's work include Advanced biosensing and bioanalysis techniques (26 papers), Advanced Nanomaterials in Catalysis (16 papers) and Electrochemical sensors and biosensors (13 papers). Jing Lü is often cited by papers focused on Advanced biosensing and bioanalysis techniques (26 papers), Advanced Nanomaterials in Catalysis (16 papers) and Electrochemical sensors and biosensors (13 papers). Jing Lü collaborates with scholars based in China, United States and Canada. Jing Lü's co-authors include Duanping Sun, James D. Winkler, Kanak Raina, Craig M. Crews, Yimin Qian, Martha Altieri, Jing Wang, Kevin Coleman, Hanqing Dong and Andrew P. Crew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jing Lü

178 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

2015 849 citations Jing Lü et al. profile →
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

2016 661 citations Jing Lü et al. profile →

Peers

Countries citing papers authored by Jing Lü

Since Specialization

Citations

This map shows the geographic impact of Jing Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lü more than expected).

Fields of papers citing papers by Jing Lü

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lü. The network helps show where Jing Lü may publish in the future.

Co-authorship network of co-authors of Jing Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Lü. A scholar is included among the top collaborators of Jing Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Lü. Jing Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SNX3 mediates heart failure by interacting with HMGB1 and subsequently facilitating its nuclear-cytoplasmic translocation 2025 ·Acta Pharmacologica Sinica ·Hong Li, (unknown), (unknown), Jianxing Chen, Yuemei Wang, Panxia Wang, Yuehuai Hu, Daniel Pan, Peiqing Liu, Jing Lü	0
2	PERK's novel agonist protects against myocardial ischemia-reperfusion injury by modulating ER-mitochondria contacts and phosphatidic acid transport 2025 ·International Journal of Cardiology ·Zeyu Li, Suiqing Huang, Huayang Li, Quan Liu, Jing Lü, Peiqing Liu, Zhongkai Wu	0
3	GPLD1 Attenuates Heart Failure via Dual-Membrane Localization to Inhibit uPAR 2025 ·Circulation Research ·(unknown), Zhen Guo, Huimin Liang, (unknown), (unknown), Zeyu Li, Jiaying Yu, (unknown), Ali Javaheri, Zhiping Liu, Duanping Sun, Peiqing Liu, Jing Lü	0
4	Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity 2025 ·Journal of Controlled Release ·Zequn Tang, Tong Su, (unknown), (unknown), Dong‐Hui Chen, Xi Li, Jing Lü, Jinzhong Lin, Teng Shen	0
5	Hydroxychloroquine-functionalized ionizable lipids mitigate inflammatory responses in mRNA therapeutics 2025 ·Journal of Controlled Release ·Kepan Chen, (unknown), (unknown), Ye Li, Ting Jiang, Yan Liu, Na Guo, Xiaoling Zeng, Hongwei Yao, Min Qiu, Jing Lü, Jinzhong Lin	1
6	Double hook-type aptamer-based colorimetric and electrochemical biosensor enables rapid and robust analysis of EpCAM expression 2024 ·Biosensors and Bioelectronics ·(unknown), (unknown), Mengjie Chen, Wen Chen, Wenjuan Ma, Jing Lü, Duanping Sun	8
7	Enhanced Electrochemical Characterization of the Immune Checkpoint Protein PD‐L1 using Aptamer‐Functionalized Magnetic Metal‐Organic Frameworks 2024 ·Advanced Healthcare Materials ·Ying Ma, Maoqiang Wu, (unknown), Zuanguang Chen, Jing Lü, Duanping Sun	15
8	Aptamer-Based Electrochemical Biosensing Platform for Analysis of Cardiac Biomarkers 2024 ·ACS Sensors ·(unknown), (unknown), (unknown), Yuan Hao, Jing Lü, Duanping Sun	8
9	Didang Tang alleviates neuronal ferroptosis after intracerebral hemorrhage by modulating the PERK/eIF2α/ATF4/CHOP/GPX4 signaling pathway 2024 ·Frontiers in Pharmacology ·Jing Lü, (unknown), Li Li, (unknown), Ying Zhang, Dongmei Zhang, Peng Xu, Liwei Sun, Jian Wang	5
10	Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles 2023 ·Journal of Controlled Release ·Xiuhua Wang, Wei Wan, (unknown), Jing Lü, Peiqing Liu	14
11	Inhibition of miR-214-3p attenuates ferroptosis in myocardial infarction via regulating ME2 2023 ·Biochemical and Biophysical Research Communications ·Fang Liu, Jing Lü, (unknown), (unknown), (unknown), Jiantao Ye, Peiqing Liu	20
12	Integrating Artificial DNAzymes with Natural Enzymes on 2D MOF Hybrid Nanozymes for Enhanced Treatment of Bacteria‐Infected Wounds 2023 ·Small ·(unknown), (unknown), Jing Lü, Duanping Sun	20
13	Anisotropic aptamer-modified DNA tetrahedra/MOF nanoprobes for enhanced colorimetric aptasensing of cardiac troponin I 2023 ·Chemical Engineering Journal ·(unknown), (unknown), Peiqing Liu, Duanping Sun, Jing Lü	20
14	An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants 2023 ·Nature Communications ·Wanbo Tai, (unknown), (unknown), Shuaiyao Lu, Guangyu Zhao, Dong Chen, Wenhai Yu, Liting Ren, (unknown), Jing Lü, (unknown), (unknown), Xu Tan, Penghua Wang, Jinzhong Lin, Qiangming Sun, Xiaozhong Peng, Gong Cheng	35
15	Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin 2020 ·Acta Pharmaceutica Sinica B ·Jianwei Zheng, Junfeng Wang, Qian Wang, (unknown), Hong Wang, Zhenhua Zhang, (unknown), Qianqian Wang, Panxia Wang, (unknown), Jing Lü, Xiaolei Zhang, Songtao Xiang, Haibin Wang, Jinping Lei, Hong-Wu Chen, Peiqing Liu, Yonghong Liu, Fanghai Han, (unknown), (unknown)	26
16	G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway 2017 ·Acta Pharmacologica Sinica ·(unknown), Jing Lü, (unknown), Yuhong Zhang, Yi Cai, Jing Yuan, Peiqing Liu, Jiantao Ye	40
17	Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation 2013 ·Blood ·Jing Lü, Tatiana Zavorotinskaya, Yumin Dai, Xiaohong Niu, Joseph Castillo, Janet Sim, Jianjun Yu, Yingyun Wang, John L. Langowski, Jocelyn Holash, Kevin Shannon, Pablo D. García	123
18	14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival 2009 ·Cancer Research ·Christopher L. Neal, Jun Yao, Wentao Yang, Xiaoyan Zhou, (unknown), Jing Lü, Christopher G. Danes, Hua Guo, Keng‐Hsueh Lan, Joe Ensor, Walter N. Hittelman, Mien‐Chie Hung, Dihua Yu	158
19	Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance 2009 ·Clinical Cancer Research ·Jing Lü, Ming Tan, Wen-Chien Huang, Ping Li, Hua Guo, Ling‐Ming Tseng, (unknown), (unknown), Warapen Treekitkarnmongkol, Michael Andreeff, Fraser Symmans, Dihua Yu	65
20	14-3-3ζ Down-regulates p53 in Mammary Epithelial Cells and Confers Luminal Filling 2008 ·Cancer Research ·Christopher G. Danes, Shannon L. Wyszomierski, Jing Lü, Christopher L. Neal, Wentao Yang, Dihua Yu	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact